financetom
Business
financetom
/
Business
/
Market Chatter: Citigroup, Goldman Sachs Hired for IPO of Titan Cement's US Unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Citigroup, Goldman Sachs Hired for IPO of Titan Cement's US Unit
Sep 6, 2024 1:15 PM

02:49 PM EDT, 09/05/2024 (MT Newswires) -- Citigroup ( C ) and Goldman Sachs (GS) were hired to help arrange a planned listing of Titan Cement's US business next year, Bloomberg reported Thursday, citing people familiar with the matter.

Titan Cement plans to raise at least $500 million by selling a minority stake through the IPO of Titan America, the report said.

Titan America could fetch a valuation of over $2 billion via the listing, according to the people.

Representatives for Titan Cement, Citigroup ( C ) and Goldman declined Bloomberg's requests for comment.

Citigroup ( C ) declined MT Newswires' request for comment, while Titan Cement and Goldman did not immediately reply.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 60.75, Change: -0.21, Percent Change: -0.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Relay Therapeutics Shares Rise Premarket on Positive Interim Data for RLY-2608 Breast Cancer Treatment
Relay Therapeutics Shares Rise Premarket on Positive Interim Data for RLY-2608 Breast Cancer Treatment
Sep 9, 2024
08:12 AM EDT, 09/09/2024 (MT Newswires) -- Relay Therapeutics ( RLAY ) shares rose more than 12% premarket after the company reported Monday that patients who received RLY-2608 demonstrated clinically meaningful progression free survival with a median of 9.2 months despite heavy pre-treatment. However, 25% of patients given RLY-2608 experienced Grade 3 treatment-related adverse events and two patients discontinued treatment....
KBR to Deploy Solvent De-Asphalting Technology to Zhejiang Petroleum in China
KBR to Deploy Solvent De-Asphalting Technology to Zhejiang Petroleum in China
Sep 9, 2024
08:08 AM EDT, 09/09/2024 (MT Newswires) -- KBR (KBR) said Monday it will provide technology licensing and engineering design of its Rose supercritical Solvent De-Asphalting technology to China-based Zhejiang Petroleum & Chemical, a unit of Rongsheng Petrochemical. Financial terms weren't disclosed. The technology will allow Zhejiang Petroleum to upgrade its residue conversion for higher profitability and operational sustainability, according to...
Tilray Medical Supports Scientific Study on Fibromyalgia With
Tilray Medical Supports Scientific Study on Fibromyalgia With "Positive Outcomes"
Sep 9, 2024
07:57 AM EDT, 09/09/2024 (MT Newswires) -- Tilray Brands ( TLRY ) said a new study examining the real-world impact of cannabinoid treatments on patients with fibromyalgia (FM) has been published in an open-access journal focused on alternative, complementary and integrative medicine. The study, which was supported by Tilray Brands' ( TLRY ) division Tilray Medical, consisted of three patients...
Market Chatter: Activist Investor Starboard Challenges Murdoch's News Corp Control
Market Chatter: Activist Investor Starboard Challenges Murdoch's News Corp Control
Sep 9, 2024
07:17 AM EDT, 09/09/2024 (MT Newswires) -- Activist investor Starboard Value privately filed a shareholder resolution to abolish News Corp's ( NWSA ) dual-class stock structure that gives Rupert Murdoch a 40% voting stock despite owning only 14% in equity, Reuters reported Friday, citing people familiar with the matter. The resolution is non-binding on News Corp ( NWSA ), Reuters...
Copyright 2023-2026 - www.financetom.com All Rights Reserved